Live

Keep up to date with our latest announcements.

On recrute !

Des camélidés aux diagnostics de demain : le LabCom NVDIAG recrute son ingénieur·e ! Lancé en décembre 2025, NVDIAG — acronyme de Nano-antibody generation using extracellular Vesicles for DIAgnostic purposes — est un laboratoire commun…

Non classé

New Publication

Our LabCom at the heart of an international collaboration! Clara Bouyx and Alain Roussel contributed to a study published in Cell Reports, alongside researchers from Nanyang Technological University Singapore, Singapore-MIT Alliance for Research…

Non classé

Focus on Zoé Jobert: Biotech engineering tackling rare diseases!

For this 3rd portrait in our series dedicated to the talents of NVDIAG LabCom, we introduce you to Zoé, a final-year student at SupBiotech, a leading biotechnology engineering school. Currently completing her end-of-studies internship, she…

Non classé

Discovering the CD96 project with Emilie LOUAT

Continuing our series of portraits dedicated to NVDIAG LabCom students, today we highlight Emilie, a Master 2 student in Biology and Health, specializing in Therapeutic Engineering and Bioproduction in Health Biotechnologies at the University…

Non classé

NVDIAG presented its advancements at AIS 2026

The NVDIAG LabCom team was very happy to be present at the 14th Antibody Industrial Symposium (AIS 2026) held in Montpellier on June 30 and July 1. It was a special opportunity to share our work on the development of nano-antibodies (nAbs)…

Non classé

Discovering the CD19 project with Ilona TESTA !

As part of our video portrait series dedicated to NVDIAG LabCom students, we're today giving the floor to Ilona, a final-year student at Polytech Marseille and enrolled in a Master 2 in Health Biology – Oncology at Faculté des sciences médicales…

Non classé

From the bench to the farm: a strategic step for our future researchers!

On May 18th, members of the NVDIAG LabCom team had the opportunity to visit Ferme Pigase near Lyon. This immersion allowed them to concretely visualize a strategic stage of their work: meeting the immunized llamas used for nano-antibody (VHH)…

Non classé

Strategic potential of the CD38 target and anti-CD38 nano-antibodies developed by NVDIAG

Strategic potential of the CD38 target and anti-CD38 nano-antibodies developed by NVDIAG In the current biotechnology development landscape, the CD38 target and anti-CD38 antibodies represent a major scientific, industrial and economic…

Non classé

New Publication

Extracellular Vesicles: A Revolution in Membrane Protein Targeting New data published by the Laboratory of Macromolecular Systems Engineering (LISM) and the Paris Institute of Ecology and Environmental Sciences (iEES-Paris) validate a unique…

Non classé

NVDIAG at the CEEVEC Matching Day 2

NVDIAG at the Heart of Extracellular Vesicle Research On March 26, 2026, the NVDIAG LabCom team was proud to participate in the Matching Day #2 of the CEEVEC Action, organized by Cancéropôle PACA at the Palais du Pharo in Marseille. This…

Non classé

NVDIAG: Powering the future of medical diagnostics through nano-antibody innovation

It marks a major milestone for collaborative research and medical innovation: the agreement establishing the NVDIAG Joint Laboratory (LabCom) has been officially signed. Supported by the French National Research Agency (ANR) and the Sud-Provence-Alpes-Côte…